Kevin T. HoganMassey Canc Ctr Virginia Commonwealth Univ关注立即认领分享关注立即认领分享基本信息浏览量:20职业迁徙个人简介暂无内容研究兴趣论文共 56 篇作者统计合作学者相似作者按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选时间引用量主题期刊级别合作者合作机构Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomasBeata Holkova,Maciej Kmieciak,Prithviraj Bose,Victor Y Yazbeck,Paul M Barr,Mary Beth Tombes,Ellen Shrader,Caryn Weirwiggins, April D Rollins,Erin Cebula,Emily Pierce,Megan M Herr,LEUKEMIA & LYMPHOMA(2016)引用22浏览0WOS引用220A Phase Ii Trial Of Azd6244 (Selumetinib, Arry-142886), An Oral Mek1/2 Inhibitor, In Relapsed/Refractory Multiple MyelomaBeata Holkova,Adriana Zingone,Maciej Kmieciak,Prithviraj Bose,Ashraf Z. Badros,Peter M. Voorhees,Rachid Baz,Neha Korde,Hui-Yi Lin,Jin-Qiu Chen, Michelle Herrmann,Liqiang Xi,CLINICAL CANCER RESEARCH(2016)引用37浏览0WOS引用370Phase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasmsBeata Holkova,Maciej Kmieciak,E Brent Perkins,Prithviraj Bose,Rachid C Baz,G David Roodman,Robert K Stuart,Viswanathan Ramakrishnan,Wen Wan,Cody J Peer,Jana L Dawson,Loveleen Kang,CLINICAL CANCER RESEARCH(2014)引用27浏览0WOS引用270Fractal organization of the human T cell repertoire in health and after stem cell transplantationJeremy Meier,Catherine Roberts,Kassi Avent,Allison Hazlett,Jennifer Berrie,Kyle Payne,David Hamm,Cindy Desmarais,Catherine Sanders,Kevin T Hogan,Kellie J Archer,Masoud H Manjili,Biology of Blood and Marrow Transplantation(2013)引用59浏览0WOS引用590Fractal Organization Of The Human T Cell Repertoire In Health And Following Stem Cell TransplantationJeremy Meier,Allison Hazlett,Kassi Avent,Jennifer Berrie,Kyle K. Payne,David Hamm,Cindy Desmarais,Catherine Sanders,Kevin T. Hogan,Steven Grant,Kellie J. Archer,Masoud H. Manjili,BLOOD(2012)引用0浏览0引用00Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasmsBeata Holkova,E Brent Perkins,Viswanathan Ramakrishnan,Mary Beth Tombes,Ellen Shrader,Neha Talreja,Martha D Wellons,Kevin T Hogan,G David Roodman,Domenico Coppola,Loveleen Kang,Jana Dawson,CLINICAL CANCER RESEARCH(2011)引用48浏览0WOS引用480Evaluation of molecular markers of mesenchymal phenotype in melanomaLeann M Mikesh,Manish Kumar,Gulsun Erdag,Kevin T Hogan,Kerrington R Molhoek,Marty W Mayo,Craig L SlingluffMELANOMA RESEARCH(2010)引用32浏览0WOS引用320The effect of intraoperative specimen inking on lumpectomy re-excision ratesMansher Singh,Gayatri Singh,Kevin T Hogan,Kristen A Atkins,Anneke T SchroenWorld journal of surgical oncology(2010)引用61浏览0WOS引用610Clonal analysis of the cytotoxic T-lymphocyte response to reovirusKEVIN T. HOGAN, L. WILLIAM CASHDOLLARViral immunology(2009)引用5浏览0WOS引用50Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded moleculesSara J. Adair,Kevin T. HoganCancer Immunology, Immunotherapy(2009)引用92浏览0WOS引用920加载更多作者统计合作学者合作机构D-Core合作者学生导师暂无相似学者,你可以通过学者研究领域进行搜索筛选数据免责声明页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn